
What does -prazole mean?
The -prazole stem marks a proton pump inhibitor. Why irreversible binding makes the effect outlast the drug, why dosing is before food, and the CYP2C19 trap.

Short answer: A drug ending in -dipine is a dihydropyridine calcium channel blocker, which acts far more on vascular smooth muscle than on cardiac muscle. That vascular selectivity is the whole stem: it explains why these drugs lower blood pressure without slowing the heart, why they cause ankle oedema, and why they behave so differently from verapamil and diltiazem despite blocking the same channel.
Generic drug names are not invented freely. The USAN Council assigns stems so that related compounds share a family name, stating plainly that the purpose is to make prescribing safer by giving immediate recognition. The WHO INN Stem Book does the same job internationally. The stem marks the dihydropyridine ring, and here chemistry maps almost perfectly onto tissue selectivity. The non-dihydropyridine calcium channel blockers, verapamil and diltiazem, carry no shared stem at all, which is itself informative: the naming system separated the group that behaves predictably from the two that do not.
L-type calcium channels appear in both vascular smooth muscle and cardiac tissue, but the channel exists in different conformational states in each, and the two chemical families bind preferentially to different states. Dihydropyridines favour the state predominating in vascular smooth muscle, while verapamil binds the state predominating in cardiac tissue. Same target, different affinity depending on where it sits, which is why one group lowers blood pressure and the other slows the heart.
Dihydropyridines dilate arterioles much more than they dilate venules. Opening the inflow while leaving the outflow unchanged raises hydrostatic pressure inside the capillary, so fluid is pushed into the surrounding tissue. Total body fluid is entirely normal, which is why a diuretic helps very little and why adding one is a common but ineffective response. An ACE inhibitor or ARB helps more, because it dilates the venous side too.
Baroreceptors respond to the rate of change in blood pressure, not only its level. A rapid fall reads as an emergency and triggers a sympathetic surge that raises heart rate and myocardial oxygen demand. This is why immediate-release nifedipine fell out of favour in hypertension while amlodipine, whose half-life runs to a day or two, causes very little of it. The difference is pharmacokinetic rather than pharmacodynamic.
Because dihydropyridines do not act meaningfully on the heart or on bronchial tissue, they avoid both the bronchospasm risk of non-selective beta blockade and the negative inotropy that makes verapamil hazardous in poor left ventricular function. That makes them a useful antihypertensive in patients with airway disease. It also means they provide no rate control, so they do nothing for atrial fibrillation.
Most dihydropyridines are CYP3A4 substrates with meaningful intestinal first-pass metabolism, so inhibiting CYP3A4 in the gut wall raises how much drug reaches the circulation. Grapefruit does exactly that. The effect is largest for felodipine and real but smaller for others. It is the same mechanism that matters for simvastatin, and recognising it as one interaction rather than two separate facts is the efficient way to hold it.
Gingival hyperplasia is an odd, well-documented effect of this class, thought to involve altered calcium flux in gingival fibroblasts changing collagen turnover. It matters in exams out of proportion to how often it is seen, because it is shared with phenytoin and ciclosporin, three unrelated drugs producing one distinctive sign. A question describing overgrown gums is usually asking you to name all three.
The dihydropyridines differ from one another mainly in how quickly they act, which is the property that decides reflex tachycardia.
| Drug | Duration | Practical note |
|---|---|---|
| Amlodipine | Very long, 35 to 50 hours | Smooth control, minimal reflex tachycardia |
| Nifedipine | Short unless modified release | Immediate release avoided in hypertension |
| Felodipine | Long | Most affected by the grapefruit interaction |
| Lercanidipine | Long, lipophilic | Reported to cause less ankle oedema |
| Nimodipine | Short, lipophilic | Used specifically in subarachnoid haemorrhage |
Once you know that -dipine means vascular, the useful next question is what happens when a calcium channel blocker is cardiac instead. Verapamil slows conduction through the atrioventricular node, which makes it useful for rate control and dangerous in heart failure or alongside a beta blocker. Nothing about that is predictable from the -dipine stem, which is precisely why the naming system did not give them one.
An unfamiliar -dipine tells you the drug is an antihypertensive acting on vessels, that it will not control rate, that ankle oedema is the likely side effect in a patient complaining of swelling, and that a CYP3A4 interaction is plausible. A question pairing an unfamiliar -dipine with atrial fibrillation is usually testing whether you know this class does not do rate control.
The same arteriolar dilation that lowers blood pressure also widens vessels in the face and in the cerebral circulation, producing flushing and a throbbing headache in the first days of treatment. These effects usually settle as the vasculature adapts, and warning patients in advance changes whether they persist with the drug. An unexplained headache in the first week of an antihypertensive is far more often this than anything sinister.
Combining a dihydropyridine with an ACE inhibitor or an ARB is common and is more than additive convenience. The renin-angiotensin blocker dilates the venous side as well as the arterial, which relieves the capillary pressure gradient responsible for ankle oedema. The combination therefore lowers blood pressure further while reducing the side effect that most often causes patients to stop, which is a genuinely rational pairing rather than a marketing one.
Nimodipine is lipophilic enough to cross the blood-brain barrier in useful quantities, and it is licensed specifically to reduce poor outcomes after aneurysmal subarachnoid haemorrhage. It is given orally rather than intravenously, because intravenous administration has been associated with severe hypotension and with fatal errors when the oral liquid was given by the wrong route. It is a reminder that tissue penetration, not just target, decides what a drug is used for.
Dihydropyridine overdose produces profound vasodilation with hypotension and a reflex tachycardia, which distinguishes it from verapamil overdose where bradycardia dominates. Management goes well beyond fluids, and calcium, high-dose insulin with glucose, and vasopressors all have a place. The distinction matters in questions because the two calcium channel blocker families, having opposite tissue selectivity, produce opposite heart rates in overdose.
The pair that tests this best is amlodipine versus nifedipine, because both act identically at the receptor and differ only in speed. The diuretics class page covers the drugs most often combined with them, and the CYP450 post explains the grapefruit interaction from the enzyme side. Then check the distinction holds with the cardiovascular practice set.
The method below works for any generic name, which is the point of learning naming as a system rather than learning drugs one at a time. Start at the end of the word, because that is where the stem almost always sits, and read backwards until you reach something familiar. Endings are assigned; beginnings are usually the manufacturer distinguishing one compound from its siblings, so the front of the name carries far less information.
Next, ask what the stem predicts. A good stem gives you a target or a chemical family, and from either you can usually derive the main effect and the principal side effect, because most adverse effects are the intended action appearing in a tissue where it was not wanted. Then look deliberately for the exception, since every stem has one and exams are built on exactly those cases.
Finally, check rather than assume. A stem narrows the possibilities; it does not replace the label. Drugs that share a target can carry different stems if their chemistry differs, and drugs that share a stem can differ enormously in duration, which is frequently the property that decides how each is used. Treat the ending as a strong hypothesis that gets you most of the way to an answer, then confirm the detail against a primary source before it matters clinically.
It marks a dihydropyridine calcium channel blocker, which acts far more on vascular smooth muscle than on cardiac tissue. That vascular selectivity explains the blood pressure effect and the characteristic side effects.
Dihydropyridines dilate arterioles much more than venules, raising capillary hydrostatic pressure so fluid moves into the tissue. Body fluid is normal, which is why diuretics help little and an ACE inhibitor or ARB helps more.
Amlodipine is a dihydropyridine acting on vessels, so it lowers blood pressure without slowing the heart. Verapamil binds the channel state predominating in cardiac tissue, so it slows atrioventricular conduction and is negatively inotropic.
Most are CYP3A4 substrates with intestinal first-pass metabolism, so the interaction applies to the group, with felodipine affected most. The mechanism is inhibition of CYP3A4 in the gut wall rather than in the liver.
Calcium channel blockers, phenytoin and ciclosporin all cause gingival hyperplasia. Three unrelated drugs producing one distinctive sign is why exams like it.
This is a stem that earns its keep by what it excludes as much as by what it includes. Knowing that -dipine means vascular tells you the drug lowers pressure, swells ankles, and will not touch heart rate, and knowing that verapamil was deliberately left outside the stem tells you it does the opposite. One ending, one tissue, and most of a therapeutic class explained.
For study only. This article is written for learning and examination practice. It is not medical advice, not clinical decision support, and must never be used to make a decision about a real patient. Always verify against your local formulary, the product literature and a qualified pharmacist.
One mechanism explained properly every day, then brought back before you forget it.
Free to download. 7-day Pro trial. No credit card.